Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Anchoring Not Significant in Treatment of AD

J Dermatolog Treat; ePub 2018 Dec 3; Curry, et al

Caregivers of children with atopic dermatitis (AD) were generally quite willing to apply topical corticosteroids once-daily if initially anchored to the idea of a 4-times-daily treatment regimen, according to a recent study that surveyed 100 caregivers of children with AD. Scores were treated as ordinal data and evaluated using the Mann-Whitney U test and chi-squared tests.

Researchers found:

  • Subjects anchored to a 4-times-daily treatment regimen were more willing to treat their child’s AD once-daily (mean, 8.7) than those not anchored (mean, 7.9), however the difference between these groups was not statistically significant.
  • For most patients with AD, anchoring may not be helpful, but for patients whose main barrier is perceived burdensomeness of treatment, anchoring may be of some benefit.

Citation:

Curry ZA, Johnson MC, Unrue EL, Feldman SR. Caregiver willingness to treat atopic dermatitis is not much improved by anchoring. [Published online ahead of print December 3, 2018]. J Dermatolog Treat. doi:10.1080/09546634.2018.1530442.